Panayiotis A. Procopiou
Stevenage, ENG SG12NY, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors.
Journal: Journal of medicinal chemistry
Published: September 13, 2024
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.
Journal: European journal of pharmacology
Published: September 30, 2021
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors.
Journal: Journal of medicinal chemistry
Published: October 26, 2020
Profile of a Highly Selective Quaternized Pyrrolidine Betaine αvβ6 Integrin Inhibitor-(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective Methylation.
Journal: Journal of medicinal chemistry
Published: August 06, 2019
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis.
Journal: Journal of medicinal chemistry
Published: September 15, 2018
A convergent strategy towards febrifugine and related compounds.
Journal: Organic & biomolecular chemistry
Published: May 23, 2018
Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis.
Journal: Bioorganic & medicinal chemistry letters
Published: August 22, 2017
Medicinal chemistry in drug discovery in big pharma: past, present and future.
Journal: Drug discovery today
Published: June 16, 2017
Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
Journal: Bioorganic & medicinal chemistry
Published: May 31, 2017
Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis.
Journal: ACS medicinal chemistry letters
Published: April 05, 2017
The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters
Published: October 06, 2016
Last Updated: 09/26/2026